1
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
Condition(s):SARS-CoV 2; InfectionLast Updated:February 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):SARS-CoV 2; InfectionLast Updated:February 21, 2023Terminated
Condition(s):Sinusitis ChronicLast Updated:January 11, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.